X. Tao

HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU

Xiaobin Lv, Wei Wu, Min Wang, 2020, Bioscience reports.

CUDC-101, a multitargeted inhibitor of histone deacetylase, epidermal growth factor receptor, and human epidermal growth factor receptor 2, exerts potent anticancer activity.

Xiong Cai, Jeffrey Forrester, Ling Yin, 2010, Cancer research.

Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non–small cell lung cancer

Xiong Cai, J. Forrester, H. Qu, 2009, Molecular Cancer Therapeutics.

CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy

Xiong Cai, J. Forrester, H. Qu, 2009, Clinical Cancer Research.

Cancer Therapy : Preclinical CUDC-305 , a Novel Synthetic HSP 90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy

Xiong Cai, J. Forrester, H. Qu, 2009 .

Preparation and anti-tumor activity of PEG-PCL polymersomes loaded with curcumol derivative in HepG2 cell line

Lijiang Chen, Fangfang He, X. Tao, 2021 .

CU-0201, a potent, small molecule, multi-targeted inhibitor of HDAC, Abl and Src, effectively inhibits proliferation of both hematological and solid-tumor derived cancer cell lines

Le Zhang, Xiong Cai, C. Qian, 2008 .